- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02180542
Atrial Fibrillation and Premature Atrial Complexes in Patients With Ischemic Stroke. (Pacific)
Atrial Fibrillation and Premature Atrial Complexes in Patients With Ischemic Stroke: Prevalence, Characteristics and Prognosis
The purpose of this study is to improve secondary prevention of ischemic stroke patients by
- Estimating prevalence and the prognostic significance of frequent premature atrial complexes in ischemic stroke patients in relation to death, recurrent stroke and atrial fibrillation.
Characterize ischemic stroke patients by
- Echocardiographic characteristics
- Biochemical markers
Plaque composition in the carotid arteries
- in order to improve risk stratification.
Study Overview
Status
Conditions
Detailed Description
Patients with atrial fibrillation (AF) have a five-fold increased risk of ischemic stroke compared to the general population. Identifying AF can be challenging, but prolonged rhythm monitoring of ischemic stroke patients have shown to enhance detection rates of AF. Therefore it is important to identify predictors of AF to allow targeted screening of patients after ischemic stroke and thereby reduce the recurrent stroke rate. Few former studies have shown an association between excessive numbers of premature atrial complexes (PACs) and AF.
The study population of ischemic stroke patients will at admission undergo following examinations:
- ECG
- 48 hours inpatient cardiac telemetry (If not known AF)
- 24 hours holter monitoring (if not known AF)
- echocardiogram
- blood sample
- CT scan of carotid arteries with contrast made on Dual Energy CT scan.
In the follow-up period, patients will have two visits with 48 hour holter monitoring (after 6 and 12 months, respectively) It will be noticed if patients have any recurrent events, die og developing AF.
The study population will be divided into four groups as follows:
- patients with new AF at admission
- patients with known AF
- patients with frequent PACs
- patients without frequent PACs. These groups will be compared on baseline characteristics and on outcome as mentioned.
The overall perspective is to make better strategies for detecting occult AF after ischemic stroke to improve secondary stroke prevention care.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Funen
-
Svendborg, Funen, Denmark, 5700
- Department of Medical Research, OUH, Svendborg
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- admitted with ischemic stroke at a single center
- time from diagnose to inclusion maximum 7 days.
- written informed consent or surrogate informed consent eligible
- age > 18 years.
Exclusion Criteria:
- hemorrhagic stroke
- terminal illness and expected lifespan of less than 6 months.
- any physical or mental condition which make the patients unsuitable for participation in the study.
- known with a pacemaker
- anticoagulation treatment of other reasons than atrial fibrillation.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Ischemic stroke patients
Patients admitted with ischemic stroke from march 2012 to april 2014
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
time to death and recurrent stroke
Time Frame: Up to 4 years
|
Up to 4 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time to death, recurrent stroke and atrial fibrillation
Time Frame: Up to 4 years
|
Up to 4 years
|
|
|
Left atrial volume and function estimated by echocardiography
Time Frame: baseline
|
descriptive comparison in between groups.
|
baseline
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
biochemical markers
Time Frame: baseline
|
descriptive comparison in between groups
|
baseline
|
|
Plaque analysis i the carotid arteries on CT
Time Frame: baseline
|
descriptive comparison in between groups.
|
baseline
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Pathologic Processes
- Heart Diseases
- Cardiovascular Diseases
- Vascular Diseases
- Cerebrovascular Disorders
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Arrhythmias, Cardiac
- Cardiac Conduction System Disease
- Pregnancy Complications
- Obstetric Labor Complications
- Obstetric Labor, Premature
- Cardiac Complexes, Premature
- Stroke
- Ischemic Stroke
- Atrial Fibrillation
- Premature Birth
- Atrial Premature Complexes
Other Study ID Numbers
- PACIFIC
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly